# Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

> **NCT06026566** · NA · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Remimazolam
- Awake Endotracheal Intubation

## Interventions

- **DRUG:** Dos of Afentanil 20
- **DRUG:** Dos of Afentanil 30
- **DRUG:** Dos of Afentanil 40
- **DRUG:** Dos of Afentanil 50
- **DRUG:** Dos of Afentanil 60
- **DRUG:** Dos of Afentanil 70
- **DRUG:** Dos of Afentanil 80
- **DRUG:** Dos of Afentanil 90
- **DRUG:** Dos of Afentanil 100

## Key facts

- **NCT ID:** NCT06026566
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026566, "Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06026566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*